Internet Explorer does not cooperate with this site. Please see below for options that work with APNA eLearning.*

4021-23: Benzos — Past and Future Considerations

This presentation will stimulate and challenge your current understanding of how you can appropriately use benzodiazepine medications. Participants will leave this presentation with the most up-to-date information on how to use this class of medication to help without hurting your clients.

Presenter:  Daniel Wesemann, DNP, PMHNP-BC, ARNP

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss the standards of care when considering using benzodiazepines.

Keywords:  Benzodiazepines, Post COVID-19 Anxiety, Best Practices

Nursing Continuing Professional Development:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 37th Annual Conference
Lake Buena Vista, FL

Access to this course will end:  November 30, 2025

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.